Cargando…

Reply to Letter to the Editor: Critique of ‘‘Dramatical Response to Low-Dose Ultra-Slow Infusion of Alteplase for Massive Mitral Mechanical Valve Thrombosis’’

Detalles Bibliográficos
Autores principales: Balaban, Fuatcan, Çoksevim, Metin, Yüksel, Serkan, Şahin, Mahmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Cardiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623188/
https://www.ncbi.nlm.nih.gov/pubmed/35943302
http://dx.doi.org/10.5152/AnatolJCardiol.2022.2070
_version_ 1784821941660549120
author Balaban, Fuatcan
Çoksevim, Metin
Yüksel, Serkan
Şahin, Mahmut
author_facet Balaban, Fuatcan
Çoksevim, Metin
Yüksel, Serkan
Şahin, Mahmut
author_sort Balaban, Fuatcan
collection PubMed
description
format Online
Article
Text
id pubmed-9623188
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Turkish Society of Cardiology
record_format MEDLINE/PubMed
spelling pubmed-96231882022-11-04 Reply to Letter to the Editor: Critique of ‘‘Dramatical Response to Low-Dose Ultra-Slow Infusion of Alteplase for Massive Mitral Mechanical Valve Thrombosis’’ Balaban, Fuatcan Çoksevim, Metin Yüksel, Serkan Şahin, Mahmut Anatol J Cardiol Letter to the Editor Reply Turkish Society of Cardiology 2022-10-01 /pmc/articles/PMC9623188/ /pubmed/35943302 http://dx.doi.org/10.5152/AnatolJCardiol.2022.2070 Text en © Copyright 2022 authors https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Letter to the Editor Reply
Balaban, Fuatcan
Çoksevim, Metin
Yüksel, Serkan
Şahin, Mahmut
Reply to Letter to the Editor: Critique of ‘‘Dramatical Response to Low-Dose Ultra-Slow Infusion of Alteplase for Massive Mitral Mechanical Valve Thrombosis’’
title Reply to Letter to the Editor: Critique of ‘‘Dramatical Response to Low-Dose Ultra-Slow Infusion of Alteplase for Massive Mitral Mechanical Valve Thrombosis’’
title_full Reply to Letter to the Editor: Critique of ‘‘Dramatical Response to Low-Dose Ultra-Slow Infusion of Alteplase for Massive Mitral Mechanical Valve Thrombosis’’
title_fullStr Reply to Letter to the Editor: Critique of ‘‘Dramatical Response to Low-Dose Ultra-Slow Infusion of Alteplase for Massive Mitral Mechanical Valve Thrombosis’’
title_full_unstemmed Reply to Letter to the Editor: Critique of ‘‘Dramatical Response to Low-Dose Ultra-Slow Infusion of Alteplase for Massive Mitral Mechanical Valve Thrombosis’’
title_short Reply to Letter to the Editor: Critique of ‘‘Dramatical Response to Low-Dose Ultra-Slow Infusion of Alteplase for Massive Mitral Mechanical Valve Thrombosis’’
title_sort reply to letter to the editor: critique of ‘‘dramatical response to low-dose ultra-slow infusion of alteplase for massive mitral mechanical valve thrombosis’’
topic Letter to the Editor Reply
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623188/
https://www.ncbi.nlm.nih.gov/pubmed/35943302
http://dx.doi.org/10.5152/AnatolJCardiol.2022.2070
work_keys_str_mv AT balabanfuatcan replytolettertotheeditorcritiqueofdramaticalresponsetolowdoseultraslowinfusionofalteplaseformassivemitralmechanicalvalvethrombosis
AT coksevimmetin replytolettertotheeditorcritiqueofdramaticalresponsetolowdoseultraslowinfusionofalteplaseformassivemitralmechanicalvalvethrombosis
AT yukselserkan replytolettertotheeditorcritiqueofdramaticalresponsetolowdoseultraslowinfusionofalteplaseformassivemitralmechanicalvalvethrombosis
AT sahinmahmut replytolettertotheeditorcritiqueofdramaticalresponsetolowdoseultraslowinfusionofalteplaseformassivemitralmechanicalvalvethrombosis